GPT Healthcare Limited (NSE:GPTHEALTH)
India · Delayed Price · Currency is INR 170.00
+3.96 (2.38%)
Jul 31, 2026, 3:29 PM IST
GPT Healthcare Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 4,725 | 4,725 | 4,071 | 4,002 | 3,610 | 3,374 |
Revenue Growth | 16.08% | 16.08% | 1.72% | 10.85% | 7.00% | 39.00% |
Gross Profit Gross Profit Growth | 2,812 | 2,812 | 2,427 | 2,354 | 2,100 | 1,840 |
Operating Income Operating Income Growth | 583.78 | 583.78 | 643.23 | 703.45 | 594.4 | 604.51 |
Net Income Net Income Growth | 422.21 | 422.21 | 499.22 | 477.69 | 390.08 | 416.63 |
Earnings Per Share EPS Growth | 5.15 | 5.15 | 6.08 | 5.96 | 4.88 | 5.21 |
EPS Growth | -15.37% | -15.37% | 2.01% | 22.13% | -6.33% | 97.36% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 471.96 | 471.96 | 364.16 | 190.31 | 168.75 | 136.61 |
Total Debt Total Debt Growth | 911.8 | 911.8 | 352.97 | 305.43 | 828.91 | 1,016 |
Net Cash (Debt) Net Cash Growth | -439.84 | -439.84 | 11.18 | -115.12 | -660.16 | -878.97 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.36 | -5.36 | 0.14 | -1.44 | -8.26 | -11.00 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 811.61 | 811.61 | 673.96 | 688 | 663.56 | 659.92 |
Capital Expenditures CapEx Growth | -418.19 | -418.19 | -499.26 | -193.67 | -98.31 | -72.96 |
Free Cash Flow Free Cash Flow Growth | 393.42 | 393.42 | 174.71 | 494.33 | 565.24 | 586.96 |
Free Cash Flow Growth | 125.19% | 125.19% | -64.66% | -12.55% | -3.70% | 58.87% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 59.50% | 59.50% | 59.61% | 58.83% | 58.16% | 54.55% |
Operating Margin | 12.35% | 12.35% | 15.80% | 17.58% | 16.46% | 17.92% |
Pretax Margin | 11.60% | 11.60% | 17.03% | 17.00% | 15.50% | 16.03% |
Profit Margin | 8.94% | 8.94% | 12.26% | 11.94% | 10.80% | 12.35% |
FCF Margin | 8.33% | 8.33% | 4.29% | 12.35% | 15.66% | 17.40% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 2.500 | 2.500 | 2.500 | 2.500 | 4.000 |
Dividend Per Share Growth | 0% | 0% | 0% | -37.50% | - |
Dividend Yield | 1.47% | 2.19% | 1.75% | 1.48% | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.13 | 22.41 | 24.16 | 30.28 | - | - |
Forward PE | 22.14 | 16.65 | 19.09 | - | - | - |
P/FCF Ratio | 35.56 | 24.05 | 69.03 | 29.26 | - | - |
PS Ratio | 2.96 | 2.00 | 2.96 | 3.62 | - | - |